CIK 1652044
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Capital Markets | 25.63% | 1 |
| Communications Equipment | 24.53% | 1 |
| Diversified Telecommunication Services | 18.46% | 1 |
| Pharmaceuticals & Biotechnology | 12.56% | 12 |
| Semiconductors & Semiconductor Equipment | 7.39% | 1 |
| Software | 6.77% | 4 |
| Software & IT Services | 1.75% | 1 |
| Commercial Services & Supplies | 1.66% | 1 |
| Insurance | 1.19% | 2 |
| Unclassified | 0.05% | 1 |
| Health Care Equipment & Supplies | 0.02% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | CME | CME GROUP INC. | Financials | 25.63% |
| 2 | PL | Planet Labs PBC | Information Technology | 24.53% |
| 3 | ASTS | AST SpaceMobile, Inc. | Communication Services | 18.46% |
| 4 | RVMD | Revolution Medicines, Inc. | Health Care | 7.97% |
| 5 | ARM | ARM HOLDINGS PLC /UK | Information Technology | 7.39% |
| 6 | FRSH | Freshworks Inc. | Information Technology | 3.24% |
| 7 | PATH | UiPath, Inc. | Information Technology | 1.94% |
| 8 | TEM | Tempus AI, Inc. | Information Technology | 1.75% |
| 9 | PAYP | PayPay Corp | Industrials | 1.66% |
| 10 | GTLB | Gitlab Inc. | Information Technology | 1.47% |
25/26 names classified · sector 99.9% of weight · industry 99.9% · mkt cap 90.9%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 99.9% of the book is sector-classified (unclassified names shown, never dropped).
Only 33% of book weight classified — the grid is NOT representative of the whole book.
Classified: 32.6% of book weight (4/26 names) · unclassified 67.4%: PL, ASTS, RVMD, ARM, PAYP, GTLB, PRME, LIFE, MAZE, BBOT +12 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | CMECME GROUP INC | 3,484,020 | $1.0B | 25.6% | NEW |
| 2 | PLPLANET LABS PBC | 35,248,893 | $985M | 24.5% | ADD 10% |
| 3 | ASTSAST SPACEMOBILE INC | 8,943,486 | $741M | 18.5% | HOLD |
| 4 | RVMDREVOLUTION MEDICINES INC | 3,292,525 | $320M | 8.0% | HOLD |
| 5 | ARMARM HOLDINGS PLC | 1,960,784 | $297M | 7.4% | HOLD |
| 6 | FRSHFRESHWORKS INC | 16,206,643 | $130M | 3.2% | HOLD |
| 7 | PATHUIPATH INC | 7,034,337 | $78M | 1.9% | HOLD |
| 8 | TEMTEMPUS AI INC | 1,551,102 | $70M | 1.7% | HOLD |
| 9 | PAYPPAYPAY CORP | 3,125,000 | $67M | 1.7% | NEW |
| 10 | GTLBGITLAB INC | 2,724,712 | $59M | 1.5% | HOLD |
| 11 | PRMEPRIME MEDICINE INC | 16,562,498 | $58M | 1.4% | HOLD |
| 12 | LIFEETHOS TECHNOLOGIES INC | 3,770,156 | $42M | 1.0% | NEW |
| 13 | MAZEMAZE THERAPEUTICS INC | 1,388,583 | $41M | 1.0% | HOLD |
| 14 | BBOTBRIDGEBIO ONCOLOGY THERAPEUTIC | 2,823,126 | $25M | 0.6% | HOLD |
| 15 | RLAYRELAY THERAPEUTICS INC | 1,564,173 | $16M | 0.4% | HOLD |
| 16 | GLUEMONTE ROSA THERAPEUTICS INC | 684,275 | $11M | 0.3% | TRIM −8% |
| 17 | VERAVERA THERAPEUTICS INC | 241,264 | $10M | 0.2% | HOLD |
| 18 | SANASANA BIOTECHNOLOGY INC | 2,812,500 | $8M | 0.2% | HOLD |
| 19 | BEAMBEAM THERAPEUTICS INC | 321,604 | $8M | 0.2% | HOLD |
| 20 | LYELLYELL IMMUNOPHARMA INC | 293,256 | $6M | 0.1% | HOLD |
| 21 | OSCROSCAR HEALTH INC | 481,988 | $6M | 0.1% | HOLD |
| 22 | FIGFIGMA INC | 215,582 | $5M | 0.1% | HOLD |
| 23 | SPROSPERO THERAPEUTICS INC | 889,979 | $2M | 0.1% | HOLD |
| 24 | HYPRHYPERFINE INC | 898,720 | $970,618 | 0.0% | HOLD |
| 25 | AUTLAUTOLUS THERAPEUTICS PLC | 698,262 | $963,602 | 0.0% | HOLD |
| 26 | TNYATENAYA THERAPEUTICS INC | 915,705 | $631,836 | 0.0% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| CMECME GROUP INC | — | — | — | — | — | 3.5M | $1.0B |
| PLPLANET LABS PBC | 31.9M | 31.9M | 31.9M | 31.9M | 31.9M | 35.2M | $985M |
| ASTSAST SPACEMOBILE INC | — | 8.9M | 8.9M | 8.9M | 8.9M | 8.9M | $741M |
| RVMDREVOLUTION MEDICINES INC | 4.1M | 4.1M | 4.1M | 4.1M | 3.3M | 3.3M | $320M |
| ARMARM HOLDINGS PLC | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | $297M |
| FRSHFRESHWORKS INC | 16.2M | 16.2M | 16.2M | 16.2M | 16.2M | 16.2M | $130M |
| PATHUIPATH INC | 7.0M | 7.0M | 7.0M | 7.0M | 7.0M | 7.0M | $78M |
| TEMTEMPUS AI INC | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | $70M |
| PAYPPAYPAY CORP | — | — | — | — | — | 3.1M | $67M |
| GTLBGITLAB INC | 6.1M | 2.7M | 2.7M | 2.7M | 2.7M | 2.7M | $59M |
| PRMEPRIME MEDICINE INC | 15.1M | 15.1M | 15.1M | 16.6M | 16.6M | 16.6M | $58M |
| LIFEETHOS TECHNOLOGIES INC | — | — | — | — | — | 3.8M | $42M |
| MAZEMAZE THERAPEUTICS INC | — | 2.4M | 2.4M | 2.4M | 1.4M | 1.4M | $41M |
| BBOTBRIDGEBIO ONCOLOGY THERAPEUTIC | — | — | — | 2.8M | 2.8M | 2.8M | $25M |
| RLAYRELAY THERAPEUTICS INC | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | $16M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
